Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPS5940819B2 - Method for producing diterpene derivative compounds - Google Patents
[go: Go Back, main page]

JPS5940819B2 - Method for producing diterpene derivative compounds - Google Patents

Method for producing diterpene derivative compounds

Info

Publication number
JPS5940819B2
JPS5940819B2 JP22910782A JP22910782A JPS5940819B2 JP S5940819 B2 JPS5940819 B2 JP S5940819B2 JP 22910782 A JP22910782 A JP 22910782A JP 22910782 A JP22910782 A JP 22910782A JP S5940819 B2 JPS5940819 B2 JP S5940819B2
Authority
JP
Japan
Prior art keywords
formula
ether
ozone
derivative compounds
treated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP22910782A
Other languages
Japanese (ja)
Other versions
JPS58113146A (en
Inventor
弘幸 秋田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RIKEN
Original Assignee
RIKEN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RIKEN filed Critical RIKEN
Priority to JP22910782A priority Critical patent/JPS5940819B2/en
Publication of JPS58113146A publication Critical patent/JPS58113146A/en
Publication of JPS5940819B2 publication Critical patent/JPS5940819B2/en
Expired legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

【発明の詳細な説明】 本発明は、 一般式: / H3CO\CH3 (1) ゛、H (R1はメトキシカルボニル基を表わす。[Detailed description of the invention] The present invention General formula: / H3CO\CH3 (1) ゛、H (R1 represents a methoxycarbonyl group.

)で表わされるジゼルペン系フェノール誘導体(1)を
オゾン酸化して芳香環を開裂せしめ、次いで、接触還元
剤又は亜鉛により処理した後、ジアゾメタンで処理して
、式二・、H (式中、R1は前記に同じ) で表わされる化合物を得ることを特徴とするジゼルペン
系誘導体化合物の製造法に関するものである。
) is oxidized with ozone to cleave the aromatic ring, then treated with a catalytic reducing agent or zinc, and then treated with diazomethane to form a diselpene phenol derivative (1) of the formula 2., H (where R1 The present invention relates to a method for producing a diselpene derivative compound, which is characterized by obtaining a compound represented by (same as above).

本発明の前記出発物質は芳香性C環を有するジゼルペン
系誘導体から誘導し得、特に1−アビエチン酸より容易
に導くことができる。
The starting materials of the present invention can be derived from diselpene derivatives having an aromatic C ring, particularly more easily than 1-abietic acid.

1−アビエチン酸は、次のような構造式を有し、〔第1
9回香料・テルペンおよび精油化学に関する討論会講演
要旨集149頁、S.MurakOshietal.A
gr.BlO.Chem.39、1167.(1975
)〕1−アビエチン酸(A)をこれらの化合物へ変換す
るには、〔A〕から容易に得られるデヒドロアビエチン
酸〔B〕の芳香性C環を(a)又は(b)方向※松相類
樹脂の主成分として容易且つ廉価に入手することができ
、すでにその立体構造を含めて構造式も、上記の如く確
定され、その全合成も達成されている。
1-Abietic acid has the following structural formula, [1st
Abstracts of the 9th Symposium on Flavor, Terpene and Essential Oil Chemistry, 149 pages, S. MurakOshietal. A
gr. BIO. Chem. 39, 1167. (1975
)] To convert 1-abietic acid (A) into these compounds, convert the aromatic C ring of dehydroabietic acid [B], which can be easily obtained from [A], in the (a) or (b) direction* It can be easily and inexpensively obtained as a main component of similar resins, and its structural formula including its three-dimensional structure has already been determined as described above, and its total synthesis has been achieved.

〔W.H.Schulleretal:J.Am.Ch
em.SOc.、83、2563(1961)、E.W
enkertetal:J.Am.Chem.SOc.
、86、2038(1964)参照〕又、l−アビエチ
ン酸〔A〕から容易に変換可能と考えられる化合物とし
て、例えば、皮膚生菌類(例えばTricOphytO
n.MicrOspOrum)に対して抗カビ活性を示
すシンナモライド(CinnamOllde)〔C〕、
カイコの幼虫の生育阻止作用を示すジメチルスシアジノ
ネート(DimethylSciadinOnate)
〔D〕がある。
[W. H. Schulleretal: J. Am. Ch
em. SOc. , 83, 2563 (1961), E. W
enkertal: J. Am. Chem. SOc.
, 86, 2038 (1964)] Also, examples of compounds that are considered to be easily convertible from l-abietic acid [A] include skin fungi (e.g., TricOphytO
n. Cinnamolide (CinnamOllde) [C], which exhibits antifungal activity against MicrOspOrum);
DimethylSciadinOnate, which inhibits the growth of silkworm larvae
There is [D].

で選択的に開裂することが必要となる。一方、レボピマ
リン酸(1ev0pimaricacid)〔E〕のオ
ゾン酸化により双環性化合物〔F〕が得られる事が報告
されているが、この方法によれば、原料であるレボピマ
リン酸〔E〕は入手が困難であり、かつオゾン酸化の収
率が悪い欠点がある。
selective cleavage is required. On the other hand, it has been reported that a bicyclic compound [F] can be obtained by ozone oxidation of levopimaric acid (1ev0pimaricacid) [E], but according to this method, the raw material levopimaric acid [E] is difficult to obtain. Moreover, it has the disadvantage of poor ozone oxidation yield.

〔S.W.Pelletieretal,.Chem.
COmmun.、1967、96参照〕本発明によれば
、前記出発物質である12−ヒドロキシ体をオゾン酸化
し、種々の還元剤で処理すると、選択的に(a)方向で
開裂の起つた所望の双環性化合物が得られ、これらは、
上記生理活性物質への変換の際の重要な合成中間体とな
りうるものである。
[S. W. Pelletier etal,. Chem.
Commun. , 1967, 96] According to the present invention, when the 12-hydroxy starting material is oxidized with ozone and treated with various reducing agents, the desired bicyclic ring is selectively cleaved in the (a) direction. are obtained, and these are
It can be an important synthetic intermediate in the conversion to the above-mentioned physiologically active substances.

以下に、本発明を詳述する。The present invention will be explained in detail below.

>まず、本発明の出発物質である式(1)で表わされ
るジゼルペン系フエノール誘導体は、例えば次の如き既
知の方法に準じてl−アビエチン酸〔A〕から容易に得
ることができる。
> First, the diselpene phenol derivative represented by formula (1), which is the starting material of the present invention, can be easily obtained from l-abietic acid [A] according to the known method as follows, for example.

CR.C.Cambie&R.A.FraniCh,.
AUSt−J−Chem゜、11、117(1971)
参照〕かくして得られた出発物質、12−ヒドロキシ体
(1)をオゾン酸化して芳香環を開裂した後、種々の還
元剤を用いて還元を行ない目的物を得ることができる。
CR. C. Cambie&R. A. Franich,.
AUSt-J-Chem゜, 11, 117 (1971)
Reference] The thus obtained starting material, 12-hydroxy compound (1), is oxidized with ozone to cleave the aromatic ring, and then reduced using various reducing agents to obtain the desired product.

オゾン酸化は溶媒中で行うが用いる溶媒は、クロロホル
ム、塩化メチレン、酢酸エチル等を用いることができる
が、特にCH2Cl2−CH3OH( 1:1)を用い
るのが有利である。
Ozone oxidation is carried out in a solvent, and the solvent used may be chloroform, methylene chloride, ethyl acetate, etc., but it is particularly advantageous to use CH2Cl2-CH3OH (1:1).

又用いるオゾンの量は大過剰量を用いるのがよく反応温
度は−80℃〜0℃の範囲が好ましい。用いる還元剤と
しては、接触還元剤(10%Pd一C触媒)又は亜鉛を
用いる0反応温度及び反応時間は、それぞれ、0〜30
℃、30分〜12時間が好ましい。
The amount of ozone used is preferably in large excess, and the reaction temperature is preferably in the range of -80°C to 0°C. As the reducing agent used, a catalytic reducing agent (10% Pd-C catalyst) or zinc is used.The reaction temperature and reaction time are respectively 0 to 30%.
C, 30 minutes to 12 hours is preferred.

溶媒は、通常一般に還元に用いられているものを用いる
ことができるが、ぐCH2Cl2−MeOH.EtOH
−H2O、水、酢酸等を用いるのが好ましい。
As the solvent, those commonly used for reduction can be used, including CH2Cl2-MeOH. EtOH
-H2O, water, acetic acid, etc. are preferably used.

次に、本発明の一例を挙げ之を図示すれば次の如くであ
る。
Next, an example of the present invention will be described as follows.

本発明方法により得られる化合物は、例えば、次の如く
である。
Examples of the compounds obtained by the method of the present invention are as follows.

なお、生成物の命名は、ラブダン(1aBdane)骨
格に従つて行なつた。8−オキソ一(13→17)−ペ
ンタノルラブダン一12・18−ジオイツク酸12・1
8−ジメチルエステル〔8−0x0−(13→17)一
PentanOrlabdan−12・18−DiOi
cAcidl2・18−DimethylEster〕
(5)。
The products were named according to the labdane (1aBdane) skeleton. 8-Oxo-(13→17)-pentanollabdan-12,18-dioic acid 12,1
8-dimethyl ester [8-0x0-(13→17)-PentanOrlabdan-12・18-DiOi
cAcidl2・18-DimethylEster]
(5).

以下本発明を実施例で説明するが、本発明は何らこれら
に限定されるものではない。実施例 1 化合物(5)の合成 12−0H体(C2lH3OO3−330)(1)5.
0007(CH2Cl2:MeOH(1:1)100m
1中)をドライアイス−アセトン冷却下、オゾンを3時
間吹き込み、室温に戻して10%Pd−Cl7を加えて
常圧接触還元に付す。
EXAMPLES The present invention will be explained below with reference to Examples, but the present invention is not limited to these in any way. Example 1 Synthesis of compound (5) 12-0H form (C2lH3OO3-330) (1)5.
0007 (CH2Cl2:MeOH (1:1) 100m
1) was cooled with dry ice and acetone, ozone was blown into it for 3 hours, the temperature was returned to room temperature, 10% Pd-Cl7 was added, and the mixture was subjected to normal pressure catalytic reduction.

水素を吸収しなくなるまで接触還元を行ない、その後口
過する。口液を濃縮後、残渣にエーテルを加え、エーテ
ル層を10%KOHで抽出する。アルカリ層は10%H
Cl溶液で酸性にしてクロロホルムから抽出する。クロ
ロホルム層及びエーテル層は各各飽和食塩水で洗浄後、
Na2sO4で脱水乾燥してそれぞれ溶媒を留去する。
クロロホルム層は溶媒留去後更にジアゾメタン−エーテ
ル溶液を加えてメチル化後、エーテルを留去する。エー
テル層(中性部) 油状物 1.7547 GLC:4A1.5% 0V−17シマライト(Shi
mallte)に担持、温度200℃TR−2.45、
2.3minその他多くあり、シリカゲルクロマトグラ
フによる精製を試みたが、精製されず、クロロホルム層
(酸性部) 油状物 3.3687 シリカゲル1007を用いてカラムクロマトグラフに付
し、石油エーテルリエーテル一2:1の溶出物から油状
物(5)1.0517(22%)をエーテル溶出部から
結晶(3)618η(14%)を得る。
Catalytic reduction is carried out until hydrogen is no longer absorbed, and then passed through the mouth. After concentrating the oral fluid, ether is added to the residue, and the ether layer is extracted with 10% KOH. Alkaline layer is 10%H
Acidify with Cl solution and extract from chloroform. After washing the chloroform layer and ether layer with each saturated saline solution,
After dehydration and drying with Na2sO4, the respective solvents were distilled off.
After distilling off the solvent, the chloroform layer is further methylated by adding a diazomethane-ether solution, and then the ether is distilled off. Ether layer (neutral part) Oil 1.7547 GLC:4A1.5% 0V-17 Simalite (Shi
supported on malle), temperature 200°C TR-2.45,
2.3min There were many others, and I tried purification with silica gel chromatography, but it was not purified, and the chloroform layer (acidic part) :1.0517 (22%) of oil (5) was obtained from the eluate of 1, and 618 η (14%) of crystal (3) was obtained from the ether eluate.

(5):n−ヘキサンから再結晶 835η無色プリズ
ム晶 Mp:94.5〜95℃元素分析(C,7H26
O5として) 理論値:C65.78H8.44 実測値:C65.83H8.37KBr IR :ν Max l74Oll725、1715?−1 NMR(CDCl3):δ 0.74S3H(10−M
e)1,18S3H(4−Me) 3.62 }それぞれS.3H(4−COOMe、 3.68 9−CH2COOMe) (3)酢酸エチル−n−ヘキサンから再結晶無色針状晶
Mp:187〜19『C元素分析(ClOH22O5
として) 理論値 C65.29H7.53 実測値 C65.5lH7.6lKBr IR :ν Max 34OOll75Oll7l6、 1645礪−1 NMR(CDCl3)δ 1.23S3H(4一Me)
1.33S3H(10−Me) 3.67S3H(COOMe) 4.63−4.83(4.73)Br.S.HWh/2
−5Hz(9−0H)5.58SIH(11−H) .EtOH UV:λ 209nm(ε=12348)Ma
x(4):(5)は、レボピマリン酸(1ev0pim
aricacid)からペレタイザ一(Pelleti
er)らの方法に従つて合成した標品と混融(混触点:
94〜95℃)しても融点降下はなく、又、IR..G
LCl畠恨は完全に一致した。
(5): Recrystallized from n-hexane 835η colorless prismatic crystal Mp: 94.5~95℃ Elemental analysis (C, 7H26
(as O5) Theoretical value: C65.78H8.44 Actual value: C65.83H8.37KBr IR: ν Max l74Oll725, 1715? -1 NMR (CDCl3): δ 0.74S3H (10-M
e) 1,18S3H(4-Me) 3.62 }S. 3H (4-COOMe, 3.68 9-CH2COOMe) (3) Recrystallized from ethyl acetate-n-hexane Colorless needle crystals Mp: 187-19 'C elemental analysis (ClOH22O5
) Theoretical value C65.29H7.53 Actual value C65.5lH7.6lKBr IR: ν Max 34OOll75Oll7l6, 1645 礪-1 NMR (CDCl3) δ 1.23S3H (4-Me)
1.33S3H (10-Me) 3.67S3H (COOMe) 4.63-4.83 (4.73) Br. S. HWh/2
-5Hz (9-0H) 5.58SIH (11-H) . EtOH UV: λ 209 nm (ε=12348) Ma
x(4):(5) is levopimaric acid (1ev0pim
aricacid) to pelletizer one (Pelleti)
(mixing point:
94-95°C), there was no decrease in the melting point, and the IR. .. G
LCl Hatake was in complete agreement.

実施例 2 化合物(5)の合成 12−0H体(1)10007(CH2Cl2:MeO
H(1:1)20m1中)をドライアイス−アセトン冷
却下、オゾンを2時間吹き込み、室温に戻して酢酸20
m1を加え、亜鉛末10tを加えて2時間30分攪拌後
、▲過する。
Example 2 Synthesis of compound (5) 12-0H compound (1) 10007 (CH2Cl2:MeO
H (1:1) in 20ml) was cooled with dry ice-acetone, ozone was blown into it for 2 hours, the temperature was returned to room temperature, and acetic acid 20ml was added.
After adding 10 tons of zinc powder and stirring for 2 hours and 30 minutes, it was filtered.

沢液を濃縮し、残渣に水を加えてエーテルから抽出する
。エーテル層を10%KOHで抽出し、アルカリ層は1
0%HClで酸性にしてクロロホルムから抽出する。ク
ロロホルム層及びエーテル層は各々飽和食塩水で洗浄し
、Na2sO4で脱水乾燥後、溶媒を留去する。クロロ
ホルム層は溶媒留去後、更にジアゾメタン−エーテル溶
液を加えてメチル化後、工ーテルを留去する。エーテル
層(中性部) 油状物 274m9 GLC:4A1.5% O−17シマライト(Shim
alite)に担持、温度 22『CtR=0.701
0.8013.8分クロロホルム層(酸性部) 油状物 702m9 GLC:4A1.5% 0V−17シマライト(Shi
mallte)に担持、温度 220℃TR=0.85
、2.05分参考:標品 TR−2.05分 残渣702〜をシリカゲル507を用いてカラムクロマ
トに付し、石油エーテルリエーテル一2:1の溶出部か
ら油状物(5)465η(50%)を得る。
Concentrate the filtrate, add water to the residue, and extract from ether. The ether layer was extracted with 10% KOH, and the alkali layer was extracted with 1
Acidify with 0% HCl and extract from chloroform. The chloroform layer and the ether layer are each washed with saturated brine, dehydrated and dried over Na2sO4, and then the solvent is distilled off. After the solvent is distilled off, the chloroform layer is methylated by adding a diazomethane-ether solution, and the ether is distilled off. Ether layer (neutral part) Oil 274m9 GLC: 4A1.5% O-17 simalite (Shim
Supported on alite), temperature 22'CtR=0.701
0.8013.8 minutes Chloroform layer (acidic part) Oily substance 702m9 GLC:4A1.5% 0V-17 Simalite (Shi
Supported on malle), temperature 220℃TR=0.85
, 2.05 minutes Reference: Standard TR-2.05 minutes Residue 702~ was subjected to column chromatography using silica gel 507, and from the eluate of petroleum ether ether 2:1 oil (5) 465η (50 %).

(5):n−ヘキサンから再結晶して、無色プリズム晶
397〜を得る。
(5): Recrystallize from n-hexane to obtain colorless prism crystals 397~.

これは標品と混融(混融融点92−93。5℃)しても
融点降下はなく、又、IR.NMR..GLCは完全に
一致した。
Even when mixed with the standard product (mixed melting point: 92-93.5°C), there was no drop in the melting point, and the IR. NMR. .. GLC was in perfect agreement.

Claims (1)

【特許請求の範囲】 1 一般式。 ▲数式、化学式、表等があります▼(1)(R_1はメ
トキシカルボニル基を表わす。 )で表わされるジテルペン系フェノール誘導体(1)を
オゾン酸化して芳香環を開裂せしめ、次いで、接触還元
剤又は亜鉛により処理した後、ジアゾメタンで処理して
、式:▲数式、化学式、表等があります▼ (式中、R_1は前記に同じ) で表わされる化合物を得ることを特徴とするジテルペン
系誘導体化合物の製造法。
[Claims] 1. General formula. ▲There are mathematical formulas, chemical formulas, tables, etc.▼(1) The diterpene phenol derivative (1) represented by (R_1 represents a methoxycarbonyl group) is oxidized with ozone to open the aromatic ring, and then a catalytic reducing agent or A diterpene derivative compound characterized in that it is treated with zinc and then treated with diazomethane to obtain a compound represented by the formula: ▲Mathematical formula, chemical formula, table, etc.▼ (in the formula, R_1 is the same as above) Manufacturing method.
JP22910782A 1982-12-27 1982-12-27 Method for producing diterpene derivative compounds Expired JPS5940819B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP22910782A JPS5940819B2 (en) 1982-12-27 1982-12-27 Method for producing diterpene derivative compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP22910782A JPS5940819B2 (en) 1982-12-27 1982-12-27 Method for producing diterpene derivative compounds

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP10838776A Division JPS5850995B2 (en) 1976-09-09 1976-09-09 Diterpene derivative compounds and their production method

Publications (2)

Publication Number Publication Date
JPS58113146A JPS58113146A (en) 1983-07-05
JPS5940819B2 true JPS5940819B2 (en) 1984-10-03

Family

ID=16886846

Family Applications (1)

Application Number Title Priority Date Filing Date
JP22910782A Expired JPS5940819B2 (en) 1982-12-27 1982-12-27 Method for producing diterpene derivative compounds

Country Status (1)

Country Link
JP (1) JPS5940819B2 (en)

Also Published As

Publication number Publication date
JPS58113146A (en) 1983-07-05

Similar Documents

Publication Publication Date Title
Stille et al. Oxirene. An intermediate in the peroxyacid oxidation of acetylenes
Mathur et al. Terpenoids—LXX: Structure of dehydrocostus lactone
Cope et al. Proximity Effects. VIII. Solvolysis of cis-Cycloöctene Oxide; Synthesis of Alcohols in the Cycloöctane Series1
Anet et al. Studies in the Wagner-Meerwein Rearrangement. Part I
CH628907A5 (en) Process for the preparation of 24,25-dihydroxycholesterol derivatives
Sondheimer et al. Syntheses in the Terpene Series. V. 1 A Synthesis of DL-1, 1, 6α, 10β-Tetramethyl-trans-decal-2β-ol-5-one, the Racemate of a Degradation Product of α-Amyrin
JPS5940819B2 (en) Method for producing diterpene derivative compounds
Meisinger et al. The Structure of a New Product from Yeast: 2-(6-Hydroxy-2-methoxy-3, 4-methylenedioxyphenyl)-benzofuran
DE2347172A1 (en) PROSTAGLANDIN E DEEP 1 SYNTHESIS
US4594192A (en) 2α-fluorovitamin D3
CH316155A (en) Process for the preparation of a 5-pregnene-17a,21-diol-3,11,20-trione-3,20-dialkylene-ketal
DE2111753A1 (en) Macrocyclic compounds and processes for their preparation
Hortmann et al. Synthesis of (-)-1, 2. beta., 3, 4, 4a, 5, 6, 7, 8, 8a. beta.-decahydro-4a. alpha., 8. beta.-dimethyl-7-oxo-2-naphthoic acid methyl ester
JPS59116285A (en) 15-halo-e-homoeburnane derivative and manufacture
Anastasis et al. Studies of chromens. Part 3. Routes to 2, 2-dimethylchroman-3-ones and 4-ethyoxycarbonyl-2, 2-dimethylchromens. Synthesis of a stable chromenopyrazolinone
FR2472573A1 (en) POLYCYCLIC DERIVATIVES OF ANTHRACENE AND NAPHTHACENE AND PROCESS FOR THEIR PREPARATION
SU673174A3 (en) Method of producing 4-dezacetooxyvincristine or salts thereof
Daniewski et al. Synthesis of the Ring d‐Building Block of (24S)‐24‐Hydroxy Vitamin D3 from Menthol, I
JPS6064975A (en) Preparation of 8alpha,12-epoxy-13,14,15,16-tetranorlabdane
Kay et al. CXLIX.—Experiments on the synthesis of the benzoterpenes. Part I. Derivatives of benzonor-p-menthane
SU1409631A1 (en) Method of producing lactone of 8-oxy-13,14,15,16-tetranorlabdanic-12 acid
JPS5850995B2 (en) Diterpene derivative compounds and their production method
Borges et al. SYNTHESIS OF (1 R, cis)-2-(3-AMINO-2, 2-DIMETHYLCYCLOBUTYL) ETHANOL, A PRECURSOR OF CYCLOBUTANE CARBOCYCLIC NUCLEOSIDES
Carstenn-Lichterfelde et al. Correlation of the diterpenoids sideritol and jativatriol
Hoffmann et al. Synthesis of 4a-, 4e-phenyladamantanones and 2, 4-o-benzenoadamantane by π-route